Literature DB >> 19337055

Family history of cancer and the risk of endometrial cancer.

Ersilia Lucenteforte1, Renato Talamini, Maurizio Montella, Luigino Dal Maso, Claudio Pelucchi, Silvia Franceschi, Carlo La Vecchia, Eva Negri.   

Abstract

To investigate the relationship between family history of cancer in first-degree relatives and the risk of endometrial cancer, we carried out a large multicentre case-control study in Italy between 1992 and 2006, including 454 endometrial cancer cases and 908 controls admitted in hospital for acute, non-neoplastic diseases. Conditional logistic regression was used to estimate odds ratios (ORs) and corresponding 95% confidence intervals (CI). Relative to women with no family history of uterine cancer, the ORs were 2.1 (95% CI: 0.7-6.4) for those reporting a family history of endometrial cancer and 1.8 (95% CI: 1.0-3.2) for a family history of any uterine cancer. A family history of intestinal cancer was directly associated with endometrial cancer risk (OR=1.6; 95% CI: 1.0-2.7). Direct associations were found for a few other cancer sites. In conclusion, a family history of endometrial, uterine or intestinal cancer in first-degree relatives is associated with an increased risk of endometrial cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19337055     DOI: 10.1097/CEJ.0b013e328305a0c9

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  16 in total

Review 1.  The inherited genetics of ovarian and endometrial cancer.

Authors:  Simon A Gayther; Paul D P Pharoah
Journal:  Curr Opin Genet Dev       Date:  2010-04-24       Impact factor: 5.578

2.  Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.

Authors:  Yakir Segev; Barry Rosen; Jan Lubinski; Jacek Gronwald; Henry T Lynch; Pal Moller; Charmaine Kim-Sing; Parviz Ghadirian; Beth Karlan; Charis Eng; Dawna Gilchrist; Susan L Neuhausen; Andrea Eisen; Eitan Friedman; David Euhus; Sun Ping; Steven A Narod
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

3.  Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer?

Authors:  Rajani Bharati; Mark A Jenkins; Noralane M Lindor; Loïc Le Marchand; Steven Gallinger; Robert W Haile; Polly A Newcomb; John L Hopper; Aung Ko Win
Journal:  Gynecol Oncol       Date:  2014-03-11       Impact factor: 5.482

Review 4.  Quantifying the Effect of Physical Activity on Endometrial Cancer Risk.

Authors:  Sarah J Kitson; Olivia Aurangzeb; Jawaria Parvaiz; Artitaya Lophatananon; Kenneth R Muir; Emma J Crosbie
Journal:  Cancer Prev Res (Phila)       Date:  2022-09-01

Review 5.  Antioxidative, Anti-Inflammatory, Anti-Obesogenic, and Antidiabetic Properties of Tea Polyphenols-The Positive Impact of Regular Tea Consumption as an Element of Prophylaxis and Pharmacotherapy Support in Endometrial Cancer.

Authors:  Piotr Olcha; Anna Winiarska-Mieczan; Małgorzata Kwiecień; Łukasz Nowakowski; Andrzej Miturski; Andrzej Semczuk; Bożena Kiczorowska; Krzysztof Gałczyński
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

6.  Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study.

Authors:  Hannah P Yang; Nicolas Wentzensen; Britton Trabert; Gretchen L Gierach; Ashley S Felix; Marc J Gunter; Albert Hollenbeck; Yikyung Park; Mark E Sherman; Louise A Brinton
Journal:  Am J Epidemiol       Date:  2012-11-21       Impact factor: 4.897

7.  Endometrial cancer and a family history of cancer.

Authors:  Linda S Cook; Harold E Nelson; Christine A Stidley; Yan Dong; Pamela J Round; Ernest K Amankwah; Anthony M Magliocco; Christine M Friedenreich
Journal:  Gynecol Oncol       Date:  2013-04-28       Impact factor: 5.482

Review 8.  Genetics of endometrial cancer.

Authors:  Ayelet Shai; Yakir Segev; Steven A Narod
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

9.  Genome-wide association study identifies a common variant associated with risk of endometrial cancer.

Authors:  Amanda B Spurdle; Deborah J Thompson; Shahana Ahmed; Kaltin Ferguson; Catherine S Healey; Tracy O'Mara; Logan C Walker; Stephen B Montgomery; Emmanouil T Dermitzakis; Paul Fahey; Grant W Montgomery; Penelope M Webb; Peter A Fasching; Matthias W Beckmann; Arif B Ekici; Alexander Hein; Diether Lambrechts; Lieve Coenegrachts; Ignace Vergote; Frederic Amant; Helga B Salvesen; Jone Trovik; Tormund S Njolstad; Harald Helland; Rodney J Scott; Katie Ashton; Tony Proietto; Geoffrey Otton; Ian Tomlinson; Maggie Gorman; Kimberley Howarth; Shirley Hodgson; Montserrat Garcia-Closas; Nicolas Wentzensen; Hannah Yang; Stephen Chanock; Per Hall; Kamila Czene; Jianjun Liu; Jingmei Li; Xiao-Ou Shu; Wei Zheng; Jirong Long; Yong-Bing Xiang; Mitul Shah; Jonathan Morrison; Kyriaki Michailidou; Paul D Pharoah; Alison M Dunning; Douglas F Easton
Journal:  Nat Genet       Date:  2011-04-17       Impact factor: 38.330

10.  GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer.

Authors:  Maxine M Chen; Tracy A O'Mara; Deborah J Thompson; Jodie N Painter; John Attia; Amanda Black; Louise Brinton; Stephen Chanock; Chu Chen; Timothy Ht Cheng; Linda S Cook; Marta Crous-Bou; Jennifer Doherty; Christine M Friedenreich; Montserrat Garcia-Closas; Mia M Gaudet; Maggie Gorman; Christopher Haiman; Susan E Hankinson; Patricia Hartge; Brian E Henderson; Shirley Hodgson; Elizabeth G Holliday; Pamela L Horn-Ross; David J Hunter; Loic Le Marchand; Xiaolin Liang; Jolanta Lissowska; Jirong Long; Lingeng Lu; Anthony M Magliocco; Lynn Martin; Mark McEvoy; Sara H Olson; Irene Orlow; Loreall Pooler; Jennifer Prescott; Radhai Rastogi; Timothy R Rebbeck; Harvey Risch; Carlotta Sacerdote; Frederick Schumacher; Veronica Wendy Setiawan; Rodney J Scott; Xin Sheng; Xiao-Ou Shu; Constance Turman; David Van Den Berg; Zhaoming Wang; Noel S Weiss; Nicholas Wentzensen; Lucy Xia; Yong-Bing Xiang; Hannah P Yang; Herbert Yu; Wei Zheng; Paul D P Pharoah; Alison M Dunning; Ian Tomlinson; Douglas F Easton; Peter Kraft; Amanda B Spurdle; Immaculata De Vivo
Journal:  Hum Mol Genet       Date:  2016-03-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.